Literature DB >> 20731451

Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles.

Haiyuan Zhang1, Moo-Yeal Lee, Michael G Hogg, Jonathan S Dordick, Susan T Sharfstein.   

Abstract

Three-dimensional (3D) cellular assays closely mimic the in vivo milieu, providing a rapid, inexpensive system for screening drug candidates for toxicity or efficacy in the early stages of drug discovery. However, 3D culture systems may suffer from mass transfer limitations, particularly in delivery of large polypeptide or nucleic acid compounds. Nucleic acids (e.g., genes, silencing RNA) are of particular interest both as potential therapeutics and due to a desire to modulate the gene-expression patterns of cells exposed to small-molecule pharmacological agents. In the present study, polyethylenimine (PEI)-coated superparamagnetic nanoparticles (SPMNs) were designed to deliver interfering RNA and green fluorescent protein (GFP) plasmids through a collagen-gel matrix into 3D cell cultures driven by an external magnetic field. The highest transfection efficiency achieved was 64% for siRNA and 77% for GFP plasmids. Delivery of an shRNA plasmid against GFP by PEI-coated SPMNs silenced the GFP expression with 82% efficiency. We further demonstrated that this delivery approach could be used for screening interfering RNA constructs for therapeutic or toxic effects for cells grown in 3D cultures. Four known toxic shRNA plasmids were delivered by PEI-coated SPMNs into 3D cell cultures, and significant toxicities (41-51% cell death) were obtained.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731451     DOI: 10.1021/nn9018812

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  23 in total

Review 1.  Magnetic nanoparticles for cancer diagnosis and therapy.

Authors:  Mehmet V Yigit; Anna Moore; Zdravka Medarova
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

2.  Multimodal magnetic core-shell nanoparticles for effective stem-cell differentiation and imaging.

Authors:  Birju Shah; Perry T Yin; Shraboni Ghoshal; Ki-Bum Lee
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

Review 3.  Nucleic acid delivery: the missing pieces of the puzzle?

Authors:  Juliane Nguyen; Francis C Szoka
Journal:  Acc Chem Res       Date:  2012-03-19       Impact factor: 22.384

4.  In vivo and ex vivo applications of gold nanoparticles for biomedical SERS imagingi.

Authors:  Mehmet V Yigit; Zdravka Medarova
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 5.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

6.  Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies.

Authors:  Hyun Jung Chung; Haeshin Lee; Ki Hyun Bae; Yuhan Lee; Jongnam Park; Seung-Woo Cho; Jin Young Hwang; Hyunwook Park; Robert Langer; Daniel Anderson; Tae Gwan Park
Journal:  ACS Nano       Date:  2011-06-06       Impact factor: 15.881

7.  Efficient transfection method using deacylated polyethylenimine-coated magnetic nanoparticles.

Authors:  Daisuke Kami; Shogo Takeda; Hatsune Makino; Masashi Toyoda; Yoko Itakura; Satoshi Gojo; Shunei Kyo; Akihiro Umezawa; Masatoshi Watanabe
Journal:  J Artif Organs       Date:  2011-05-03       Impact factor: 1.731

Review 8.  Biocompatibility assessment of Si-based nano- and micro-particles.

Authors:  Hamsa Jaganathan; Biana Godin
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

9.  Theranostic agents for intracellular gene delivery with spatiotemporal imaging.

Authors:  Jennifer M Knipe; Jonathan T Peters; Nicholas A Peppas
Journal:  Nano Today       Date:  2013-02-01       Impact factor: 20.722

10.  Transfection in the third dimension.

Authors:  Anandika Dhaliwal; Victor Oshita; Tatiana Segura
Journal:  Integr Biol (Camb)       Date:  2013-10       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.